Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinal transplantation: progress and problems in clinical application.

R D Lund1, S J Ono, D J Keegan

  • 1Moran Eye Center, University of Utah, Salt Lake City, UT 84132, USA. raymond.lund@hsc.utah.edu

Journal of Leukocyte Biology
|July 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Cases of Puerperal Peritonitis.

Western journal of medicine and surgery·2024
Same author

Kondo quasiparticle dynamics observed by resonant inelastic x-ray scattering.

Nature communications·2022
Same author

A typology of North Sea oil and gas platforms.

Scientific reports·2022
Same author

Association of glucose metabolism and blood pressure during pregnancy with subsequent maternal blood pressure.

Journal of human hypertension·2021
Same author

Association between fear of hypoglycemia and physical activity in youth with type 1 diabetes: The SEARCH for diabetes in youth study.

Pediatric diabetes·2020
Same author

Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for Diabetes in Youth  Study.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same journal

Correction to: IL-27 signaling negatively regulates FcɛRI-mediated mast cell activation and allergic response.

Journal of leukocyte biology·2026
Same journal

Autofluorescence enables detection and quantification of EETosis in human leukocyte cultures.

Journal of leukocyte biology·2026
Same journal

Cold Atmospheric Plasma as an Immunomodulator: Suppression of T-cell Hyperactivation and Graft-versus-Host Disease via Redox Regulation.

Journal of leukocyte biology·2026
Same journal

Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis.

Journal of leukocyte biology·2026
Same journal

Eosinophil Essentials: Identification and Assessment of Activity.

Journal of leukocyte biology·2026
Same journal

Immune cell landscape reveals 5 immune-related subtypes and molecular characteristics with prognostic and therapeutic implications in pan-cancer.

Journal of leukocyte biology·2026
See all related articles

Retinal cell transplantation shows promise for blindness but faces challenges. Overcoming immune rejection and improving graft survival are key for clinical success in treating retinal degeneration.

Area of Science:

  • Ophthalmology
  • Immunology
  • Regenerative Medicine

Background:

  • Millions worldwide suffer from blinding retinal degeneration, with no effective treatments.
  • Retinal cell transplantation offers potential but clinical translation remains elusive.
  • Previous studies highlight the complexity of achieving viable treatments.

Purpose of the Study:

  • To review the progress of retinal transplant studies.
  • To identify obstacles hindering clinical application of retinal transplantation.
  • To emphasize the role of immune privilege and MHC molecules in graft outcomes.

Main Methods:

  • Literature review of retinal transplant studies.
  • Analysis of factors affecting graft survival and efficacy.

Related Experiment Videos

  • Discussion of immunological challenges in retinal transplantation.

    • Main Results:

    • Retinal transplantation faces significant hurdles in graft survival and efficacy.
    • The immunological privilege of the eye presents unique challenges.
    • Major histocompatibility complex (MHC) classes I and II play a critical role in graft rejection.

    Conclusions:

    • Further research is needed to overcome immunological barriers for successful retinal transplantation.
    • Developing effective clinical protocols requires addressing graft survival and immune responses.
    • Understanding the eye's immune privilege is crucial for advancing retinal cell therapies.